Mary Reumuth's Planned Sale of KALA BIO, Inc. Securities

Mary Reumuth, an officer of KALA BIO, Inc., has filed a Form 144 notice indicating her intent to sell 32,230 shares of common stock. The shares were acquired through the vesting of restricted stock and performance shares between June 25, 2021, and October 26, 2022. The planned sale is scheduled for October 22, 2025, with an aggregate market value of $26,728.34. The securities are held on the NASDAQ exchange, and the sale will be facilitated by Morgan Stanley Smith Barney LLC Executive Financial Services. No securities were sold in the past three months.